New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers. www.oncology.ox.ac.uk/about-us/wor...

NEW: Oxford researchers have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings. Find out more ⬇️

Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.

Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning. TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations. Read more ⬇️

Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬 The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.

Congratulations to the team at Brighton and Sussex for recruiting 61 participants to SCOOT. @uhsussex.bsky.social @chestconsultant.bsky.social @oncology.ox.ac.uk #lungcancer #personalisedtherapy and #earlydiagnosis

In case you missed it! Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford! Read more ⬇️ @sarahblagden.bsky.social @medsci.ox.ac.uk www.cancer.ox.ac.uk/news/profess...

Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight! 📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4. Brought to you by @CR_UK. #CancerDetectives #CancerPrevention www.channel4.com/programmes/c...

We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2

World’s first lung cancer prevention vaccine gets £2 million for clinical trial People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. @medsci.ox.ac.uk @oxfordcancer.bsky.social

Next up in the Meet The MILI Team series, is Dr Schaida Schirwani. Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton. #LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk @oxfordcancer.bsky.social tp53.co.uk/lfs-tp53/

What if we could stop #Cancer before it even starts? Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast. 🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou... @sarahblagden.bsky.social @medsci.ox.ac.uk

INTREPID is one of five interdisciplinary teams launched as part of a new UK initiative to transform disease research through the development of advanced human tissue models. The team will evaluate & optimise the use of patient-derived explants as tumour models. Learn more:

Funded PhD available working with us on tumour hypoxia and radiosensitivity at @oncology.ox.ac.uk @ox.ac.uk Closing date 2nd Dec www.oncology.ox.ac.uk/study-with-u...

Sruthi Shakthivel is a technician in the Translational Support Unit (TSU), a dedicated unit within @octooxford.bsky.social that focuses on the operational & scientific side of biological sample management in clinical trials. Sruthi shares insights on the mission of the TSU & what her role involves:

#WIMMReads Fairfax Group ( @bpfairfax.bsky.social ) map how genetic variation shapes monocyte gene expression and splicing across immune contexts 🧪 Read more 👇 doi.org/10.1038/s414... #Genomics #Immunology #Transcriptomics

Members of the Department of Oncology were at ESMO 2025 in Berlin last week to present their research, chair sessions, and network with collaborators. Read about some of the highlights from our department’s contributions to the congress: www.oncology.ox.ac.uk/news/esmo-2025

Explore internships and graduate roles with organisations from a variety of technical area the Science, Engineering & Technology Fair @ox.ac.uk 📅 Saturday 25 October 2025 ⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45 📍 Examination Schools, OX1 4BG 👉 www.careers.ox.ac.uk/set

We would like to congratulate our MSc course prize winners, who each achieved the highest mark in their cohort for 2024-25. Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.

For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine offered the perfect opportunity to enhance her knowledge and skills, while continuing her work in the lab. Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇

Excited to share I’ve recently started as a group leader at the University of Oxford @oncology.ox.ac.uk, @ox.ac.uk Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers). #NewPI #CancerResearch

💚 Mental health matters every day. Whether you’re thriving or finding things tough, we have resources available to support you. From Spectrum.Life’s 24/7 free and confidential service, to Thriving at Oxford, and peer support. Find what helps you: www.medsci.ox.ac.uk/...

Fantastic news from Dr Peter Kok-Ting Wan, who has been awarded a fellowship from @pancreaticcanuk.bsky.social Dr Wan’s fellowship will focus on developing a novel antibody-based immunotherapy designed to overcome fibroblast-mediated shielding & restore immune activity within pancreatic tumours ⬇️

Grace Frost studied MSc Medical Physics with Radiobiology to kickstart her career in space research She is now working as a bioinformatician at the Oxford Space Innovation lab, the first to send human tissue samples to the ISS, looking at the impact of microgravity & cosmic radiation on ageing.

The Knowledge Centre Library (in the Old Road Campus Research Building) is holding a Welcome Event for new and existing University members, from the 6 - 10 October 2025, 12 - 1pm. Free tea, coffee and biscuits will be available. @oxpop.bsky.social @ndm.ox.ac.uk @medsci.ox.ac.uk @oncology.ox.ac.uk

New findings in @natcomms.nature.com demonstrate the impact of allelic variation on monocyte context-specific splicing. @bpfairfax.bsky.social & colleagues show that many risk polymorphisms lead to differential gene splicing. ➡️Reveals putative mechanisms of diverse disease risk alleles inc. cancer

Our Peer Mentoring Scheme, supported by the UK Civil Service Policy Profession is open for applications! Since 2021, it has brought together nearly 200 @ox.ac.uk researchers and policy professionals from across UK give and local authorities. Apply and share! 1/5 www.ox.ac.uk/research/usi...

📝The MSc in Radiobiology course is now accepting applications for 2026/27. The course looks in depth at principles of radiobiology & their clinical applications, for those interested in careers in academic research, clinical practice or industry. 📍See oncology.ox.ac.uk/study-with-us for details

Lots of congratulations to Tianming Zhao @oncology.ox.ac.uk who defended his MRes fantastically yesterday! This is a great story led by @mtjackson101.bsky.social (who defended his DPhil in Jan) that we hope to share soon - congratulations Tianming!

What an achievement! Delighted to have Dr Orlando join our team 👩‍🔬🧪 @oxfordcancer.bsky.social @medsci.ox.ac.uk

💡New insights into how FLASH RT kills cancer cells while minimising damage to healthy tissues. New data from @moonejung.bsky.social's lab has demonstrated that FLASH RT induces iron-dependent cell death in tumour cells but not in healthy cells, which may contribute to its tissue sparing effect⬇️

Behind every door is a discovery... 📅 On 13 Sept, we’re opening ours at the Old Road Campus Research Building for #OxfordOpenDoors. @cmd.ox.ac.uk, @idrm.ox.ac.uk, @ludwigcancer.bsky.social, @oncology.ox.ac.uk and more will be there, will you? Find out more 👉 buff.ly/WV8TAXt

Save the date! 📢 The next Oxford Cancer Symposium will take place on Tues, 31st March 2026 at the University's Mathematical Institute. Save the date in your diary for now and keep an eye on our website for further updates! ⬇️ @medsci.ox.ac.uk @oncology.ox.ac.uk www.cancer.ox.ac.uk/news/save-th...

🎓New Vacancy: Principal Scientist/Deputy Director of Education. Responsible for leading the development of the Department of Oncology’s suite of postgraduate taught courses and strengthening the existing provision of postgraduate research training. Deadline: 30 Sep. See more: tinyurl.com/3js9ssud

Congratulations to Matt Jackson who has been awarded his first project grant through the @medsci.ox.ac.uk Internal Fund Pump-Priming Scheme 🥳 This award will allow Matt to build on initial findings from his doctoral research, investigating the fundamental cell biology of CD8+ T cells.

One week left to apply for the postdoc position in my lab at Oxford @ox.ac.uk Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social. Deadline: 11 August 2025 (noon).

A very fulfilling role for the past year, with a great outcome!🏅🍃🏅

Congratulations to Simon Lord who has received an NIHR EME award to study the impact of insulin levels on breast cancer treatment response. Trans-EndoNET will investigate the relationship between insulin resistance & response to aromatase inhibitors in patients with ER-positive breast cancer.

‘The GPTP53 trust have published some more information about the MILI trial. Visit their website to find out more: www.tp53.org.uk/mili-trial-f... #LFS #LiFraumeniSyndrome @oncology.ox.ac.uk @oxfordcancer.bsky.social

We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis. Deadline: 11 August 2025 my.corehr.com/pls/uoxrecru... Lab info: www.oncology.ox.ac.uk/team/jie-yang

Oncology researchers have uncovered how cells identify and repair DNA-protein crosslinks (DPCs): harmful DNA lesions that cause cancer, neurodegeneration, and premature ageing. Led by Kristijan Ramadan, the work has important implications for improving cancer therapy & healthy ageing.

📣New Vacancy We have an exciting opportunity to join the Yang group, conducting research on T cell immunity & immunosuppression in cancer, with focus on understanding and enhancing immunity for the prevention of cancer development and spread. Find out more: tinyurl.com/vjxyk7u6

A new UK-wide clinical study aimed at transforming liver cancer surveillance in people with #cirrhosis has opened to recruitment oxfordbrc.nihr.ac.uk/recruitment-... #LiverCancer @ouhospitals.bsky.social @medsci.ox.ac.uk @rdm.ox.ac.uk @nihr.bsky.social

Researchers are encouraged to apply to access a national database of research volunteers to aid recruitment to trials supported by the NIHR. Learn more about how the service works and submit a study registration form: tinyurl.com/4s6m3uje #BePartofResearch

A huge thanks to everyone who attended our OCION Symposium last week! Congratulations to our poster prize winner, Matthew Jackson, and runner up, Paul Tarlatt, from @oxcio.bsky.social!! Read all about the day on our website ⬇️ www.cancer.ox.ac.uk/news/action-...

Applications for the Rhodes Scholarship 2026 are now open! The Rhodes Scholarship is a fully-funded postgraduate award which enables talented young people from around the world to study full-time at @ox.ac.uk Find out more: www.rhodeshouse.ox.ac.uk/scholarships... @rhodeshouse.ox.ac.uk

The 2025 Oxford Cancer Immuno-Oncology Network Funding Scheme is now officially open! Applications for up to £20,000 to pump-prime innovative, high-risk and proof-of-concept Oxford-based immuno-oncology research are welcomed. Full details on our website 👇 www.cancer.ox.ac.uk/news/OCION_P...

Abstract Submission fast approaching - 11th July 2025

Now hiring: Research Assistant in Organoid/iPSCs models 🧬 This exciting role will support research on the role of RAS pathway activation in gene regulation & tumour development in colorectal cancer. Seeking: Graduate with an interest in epigenetics, cancer biology & the TME ➡️ tinyurl.com/43nhf9bj